1.
Expert Rev Anticancer Ther
; 9(1): 135-42, 2009 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19105713
RESUMO
Gastric cancer is the second leading cause of cancer death worldwide. The local surgical treatment of gastric cancer varies geographically. However, there has been a confluence of opinion regarding the optimal therapy of gastric cancer toward multimodality therapy. In the East, many clinicians pursue adjuvant chemotherapy after a D2 resection. However, in the West, clinicians use either perioperative chemotherapy or postoperative chemoradiation. It remains unclear at this time whether either perioperative approach is the optimal approach.